Open an account

X T L Biopharmaceuticals

XTLB · TEL

$2.02+$0.05 (+2.54%)TodayMarket closed ·
Prev close $1.97

About XTLB

XTL Biopharmaceuticals Ltd. engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases. The firm pipelines include hCDR1 systematic lupus erythematosus and recombinant human erythropoietin (rHuEPO) multiple myeloma. Its hCDR1, which is a potential treatment for systemic lupus erythematosus (SLE) and Sjogren's syndrome (SS). hCDR1 is a peptide that is administered subcutaneously and acts as a disease-specific treatment to modify the SLE-related autoimmune process. The rHuEPO known agent for anemia to prolong a survival of patients for treatment of multiple myeloma blood cancer. Its Erythropoietin (EPO) is a glycoprotein hormone produced mainly by kidneys. EPO stimulates erythropoiesis, production of red blood cells, by binding to its receptor on a surface of erythroid progenitor cells, promoting their proliferation and differentiation and maintaining their viability.

Employees
33
Headquarters
Ramat Gan
Listed
Sep 1, 2000
Sector
Health Care
Industry
Biotechnology
Website
xtlbio.com

XTLB key statistics

Market cap
25.41M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
9.41K
Volume
3.90K
Open price
$1.95
High today
$2.02
Low today
$1.97
52 Week high
$5.64
52 Week low
$1.78

X T L Biopharmaceuticals (XTLB) at a glance

As of Oct 23, 2026, X T L Biopharmaceuticals (XTLB) shares are priced at $2.02, giving the company a market cap of 25.41M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $1.97 and $2.02. The current price is 2.5% above the day's low and 0.0% below its high.

Volume so far is 3.90K shares, below the average of 9.41K shares a day.

Over the past year X T L Biopharmaceuticals has ranged from $1.78 to $5.64, and now sits 6% of the way up that range.

XTLB news

  • 12 Health Care Stocks Moving In Wednesday's Pre-Market Session

  • 12 Health Care Stocks Moving In Friday's After-Market Session

  • Avi Kapoor

    Crude Oil Jumps 5%; Automatic Data Processing Posts Upbeat Earnings

  • Avi Kapoor

    Dow Falls 100 Points; Brinker Earnings Beat Estimates

  • 12 Health Care Stocks Moving In Friday's After-Market Session

  • 12 Health Care Stocks Moving In Tuesday's Intraday Session

  • 12 Health Care Stocks Moving In Friday's Pre-Market Session

Similar companies

Companies in the same industry as X T L Biopharmaceuticals

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.